These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10967665)

  • 1. [Reversible posterior leukoencephalopathy in a patient receiving cyclosporine therapy].
    Ikeda M
    Rinsho Shinkeigaku; 2000 Apr; 40(4):412-3. PubMed ID: 10967665
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute posterior leukoencephalopathy in a patient with nephrotic syndrome.
    Utsumi K; Amemiya S; Iizuka M; Iino Y; Katayama Y
    Clin Exp Nephrol; 2003 Mar; 7(1):63-6. PubMed ID: 14586746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible everolimus-induced, severe, reversible encephalopathy after cardiac transplantation.
    Tsagalou EP; Anastasiou-Nana MI; Margari ZJ; Vassilopoulos D
    J Heart Lung Transplant; 2007 Jun; 26(6):661-4. PubMed ID: 17543796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible posterior leukoencephalopathy caused by azathioprine in systemic lupus erythematosus.
    Foocharoen C; Tiamkao S; Srinakarin J; Chamadol N; Sawanyawisuth K
    J Med Assoc Thai; 2006 Jul; 89(7):1029-32. PubMed ID: 16881437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cyclosporin A-induced posterior reversible encephalopathy syndrome (PRES) in MRI].
    Herzog H; Zuber J; Stroszczynski C
    Rofo; 2004 Sep; 176(9):1326-7. PubMed ID: 15346269
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversible posterior leukoencephalopathy syndrome: a retrospective study in King Chulalongkorn Memorial Hospital.
    Tungkasaereerak C; Phanthumchinda K
    J Med Assoc Thai; 2008 Mar; 91(3):427-32. PubMed ID: 18575300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posterior leukoencephalopathy with cyclosporine.
    Chow KM; Szeto CC
    Clin Nephrol; 2003 Oct; 60(4):297-8; author reply 298. PubMed ID: 14579949
    [No Abstract]   [Full Text] [Related]  

  • 8. [Reversible cyclosporin A-induced leukoencephalopathy: a case report and differential diagnosis discussion].
    Lingesleben A; Hoffmann KT; Oppert M; Irlbacher K; Röricht S; Meyer BU
    Rontgenpraxis; 2000; 53(1):25-8. PubMed ID: 10943139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posterior leukoencephalopathy syndrome in children and adolescents.
    Alehan F; Erol I; Agildere AM; Ozcay F; Baskin E; Cengiz N; Alioglu B; Haberal M
    J Child Neurol; 2007 Apr; 22(4):406-13. PubMed ID: 17621519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Severe hemolysis during immunosuppressive therapy with cyclosporin A following kidney transplantation].
    Kirste G; Wilms H; Hörl W; Steinhauer HB
    Dtsch Med Wochenschr; 1985 Apr; 110(16):655-6. PubMed ID: 3886342
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancers following cyclosporine therapy.
    Penn I
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2211-3. PubMed ID: 3274495
    [No Abstract]   [Full Text] [Related]  

  • 12. [Metabolic encephalopathies. II].
    Dixneuf B; Nicolas F
    Anesth Analg (Paris); 1971; 28(1):57-92. PubMed ID: 5556238
    [No Abstract]   [Full Text] [Related]  

  • 13. Posterior reversible encephalopathy syndrome due to sirolimus.
    Moskowitz A; Nolan C; Lis E; Castro-Malaspina H; Perales MA
    Bone Marrow Transplant; 2007 May; 39(10):653-4. PubMed ID: 17384653
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporin neurotoxicity after chemotherapy. Cyclosporin causes reversible posterior leukoencephalopathy syndrome.
    Lewis MB
    BMJ; 1999 Jul; 319(7201):54-5. PubMed ID: 10523082
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurological complications of liver transplantation in pediatric patients: a single center experience.
    Erol I; Alehan F; Ozcay F; Canan O; Haberal M
    Pediatr Transplant; 2007 Mar; 11(2):152-9. PubMed ID: 17300494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reversible posterior leukoencephalopathy syndrome in patients with immunosuppressive treatment: report of four cases].
    Hernández Ch M; Núñez F A; Mesa L T; Escobar H R; Barriga C F; Huete L I
    Rev Med Chil; 2008 Jan; 136(1):93-8. PubMed ID: 18483659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine-associated central nervous system toxicity.
    N Engl J Med; 1988 Mar; 318(12):788-9. PubMed ID: 3347234
    [No Abstract]   [Full Text] [Related]  

  • 18. Linezolid-induced posterior reversible leukoencephalopathy syndrome.
    Nagel S; Köhrmann M; Huttner HB; Storch-Hagenlocher B; Schwab S
    Arch Neurol; 2007 May; 64(5):746-8. PubMed ID: 17502475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible posterior leukoencephalopathy syndrome associated with tacrolimus therapy.
    Nakazato T; Nagasaki A; Nakamura K; Okudaira T; Oshiro A; Miyagi T; Shinjo T; Taira N; Masuda M; Takasu N
    Intern Med; 2003 Jul; 42(7):624-5. PubMed ID: 12879959
    [No Abstract]   [Full Text] [Related]  

  • 20. Posterior reversible encephalopathy syndrome: another manifestation of CNS SLE?
    Ishimori ML; Pressman BD; Wallace DJ; Weisman MH
    Lupus; 2007; 16(6):436-43. PubMed ID: 17664235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.